1. Khan, HTA . Population ageing in a globalized world: Risks and dilemmas? J Eval Clin Pract 2019;25:754–760.
Google Scholar | Crossref | Medline2. Triposkiadis, F, Giamouzis, G, Parissis, J, et al. Reframing the association and significance of co-morbidities in heart failure. Eur J Heart Fail 2016;18:744–758.
Google Scholar | Crossref | Medline3. Rocca, WA, Boyd, CM, Grossardt, BR, et al. Prevalence of multimorbidity in a geographically defined American population: Patterns by age, sex, and race/ethnicity. Mayo Clin Proc 2014;89:1336–1349.
Google Scholar | Crossref | Medline4. Barnett, K, Mercer, SW, Norbury, M, Watt, G, Wyke, S, Guthrie, B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet 2012;380:37–43.
Google Scholar | Crossref | Medline | ISI5. Willadsen, TG, Siersma, V, Nicolaisdóttir, DR, et al. Multimorbidity and mortality: A 15-year longitudinal registry-based nationwide Danish population study. J Comorb 2018;8:2235042X18804063.
Google Scholar | SAGE Journals6. Ponikowski, P, Voors, AA, Anker, SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2016;37:2129–2200.
Google Scholar | Crossref | Medline | ISI7. Xanthopoulos, A, Butler, J, Parissis, J, Polyzogopoulou, E, Skoularigis, J, Triposkiadis, F. Acutely decompensated versus acute heart failure: Two different entities. Heart Fail Rev 2020;25(6):907–916.
Google Scholar | Crossref | Medline8. McDonagh, TA, Metra, M, Adamo, M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–3726.
Google Scholar | Crossref | Medline9. Mebazaa, A, Yilmaz, MB, Levy, P, et al. Recommendations on pre-hospital and early hospital management of acute heart failure: A consensus paper from the heart failure association of the European society of cardiology, the European society of emergency medicine and the society of academic emergency medicine--short version. Eur Heart J 2015;36:1958–1966.
Google Scholar | Medline | ISI10. Hollenberg, SM, Warner Stevenson, L, Ahmad, T, et al. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: A report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol 2019 74:1966–2011.
Google Scholar | Crossref | Medline11. Lang, RM, Badano, LP, Mor-Avi, V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–271.
Google Scholar | Crossref | Medline12. Triposkiadis, F, Xanthopoulos, A, Parissis, J, Butler, J, Farmakis, D. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev 2020, Online ahead of print. doi:10.1007/s10741-020-09987-z.
Google Scholar | Crossref13. Knuuti, J, Wijns, W, Saraste, A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407–477.
Google Scholar | Crossref | Medline14. Thygesen, K . What’s new in the fourth universal definition of myocardial infarction? Eur Heart J 2018;39:3757–3758.
Google Scholar | Crossref | Medline15. GOLD REPORT 2021. https://goldcopd.org/wp-content/uploads/2020/03/GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf. Accessed on 10 October 2021.
Google Scholar16. Pearson-Stuttard, J, Ezzati, M, Gregg, EW. Multimorbidity-a defining challenge for health systems. Lancet Public Health 2019;4:e599–e600.
Google Scholar | Crossref | Medline17. Nguyen, H, Manolova, G, Daskalopoulou, C, Vitoratou, S, Prince, M, Prina, AM. Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies. J Comorb 2019;9:2235042X19870934.
Google Scholar | SAGE Journals18. Triposkiadis, F, Starling, RC, Boudoulas, H, Giamouzis, G, Butler, J. The cardiorenal syndrome in heart failure: Cardiac? Renal? Syndrome? Heart Fail Rev 2012;17:355–366.
Google Scholar | Crossref | Medline | ISI19. Greene, SJ, Hernandez, AF, Dunning, A, et al. Hospitalization for recently diagnosed versus worsening chronic heart failure: From the ASCEND-HF trial. J Am Coll Cardiol 2017;69:3029–3039.
Google Scholar | Crossref | Medline20. Younis, A, Mulla, W, Goldkorn, R, et al. Differences in mortality of new-onset (De-Novo) acute heart failure versus acute decompensated chronic heart failure. Am J Cardiol 2019;124:554–559.
Google Scholar | Crossref | Medline21. Bazick, HS, Chang, D, Mahadevappa, K, Gibbons, FK, Christopher, KB. Red cell distribution width and all-cause mortality in critically ill patients. Crit Care Med 2011;39:1913–1921.
Google Scholar | Crossref | Medline | ISI22. Danese, E, Lippi, G, Montagnana, M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis 2015;7:E402–E411.
Google Scholar | Medline | ISI23. Xanthopoulos, A, Giamouzis, G, Melidonis, A, et al. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol 2017;16:81.
Google Scholar | Crossref | Medline24. Klein, L, Massie, BM, Leimberger, JD, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF). Circ Heart Fail 2008;1:25–33.
Google Scholar | Crossref | Medline | ISI25. Fonarow, GC, Adams, KF, Abraham, WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 2005;293:572–580.
Google Scholar | Crossref | Medline | ISI26. Ren, X, Qu, W, Zhang, L, et al. Role of blood urea nitrogen in predicting the post-discharge prognosis in elderly patients with acute decompensated heart failure. Sci Rep 2018;8:13507.
Google Scholar | Crossref | Medline27. Jujo, K, Minami, Y, Haruki, S, et al. Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure. ESC Heart Fail 2017;4:545–553.
Google Scholar | Crossref | Medline28. Lundsgaard, C, Hamberg, O, Thomsen, OO, Nielsen, OH, Vilstrup, H. Increased hepatic urea synthesis in patients with active inflammatory bowel disease. J Hepatol 1996;24:587–593.
Google Scholar | Crossref | Medline29. Beier, K, Eppanapally, S, Bazick, HS, et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of “normal” creatinine. Crit Care Med 2011;39:305–313.
Google Scholar | Crossref | Medline30. Schrier, RW . Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 2008;1:2–5.
Google Scholar | Crossref | Medline | ISI31. Kazory, A . Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 2010;106:694–700.
Google Scholar | Crossref | Medline | ISI32. Purek, L, Laule-Kilian, K, Christ, A, et al. Coronary artery disease and outcome in acute congestive heart failure. Heart 2006;92:598–602.
Google Scholar | Crossref | Medline33. Sharma, A, Zhao, X, Hammill, BG, et al. Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: Insights from the get with the guidelines-heart failure registry. Circ Heart Fail 2018;11:e004646.
Google Scholar | Crossref | Medline34. Bhatt, AS, Ambrosy, AP, Dunning, A, et al. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. Eur J Heart Fail 2020;22:1022–1031.
Google Scholar | Crossref | Medline35. Streng, KW, Nauta, JF, Hillege, HL, et al. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol 2018;271:132–139.
Google Scholar | Crossref | Medline36. Triposkiadis, F, Butler, J, Abboud, FM, et al. The continuous heart failure spectrum: Moving beyond an ejection fraction classification. Eur Heart J 2019;40:2155–2163.
Google Scholar | Crossref | Medline37. De Rango, P . Prospective cohort studies. Eur J Vasc Endovasc Surg 2016;51:151.
Google Scholar | Crossref | Medline38. Ketteler, M, Block, GA, Evenepoel, P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: Synopsis of the kidney disease: Improving global outcomes 2017 clinical practice guideline update. Ann Intern Med 2018;168:422–430.
Google Scholar | Crossref | Medline